This metastatic feature of IL-1β was further characterized by the upregulation of IL-1β via CAF-secreted CXCL11, resulting in increased migratory properties of HCC cells, as demonstrated in vitro and in vivo [125]. This evidence concerns the gene CXCL11 and hepatocellular carcinoma.